Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd share price and stock overview

Shukra Pharmaceuticals Ltd (NSE: SHUKRAPHAR, BSE: 524632) operates in the Pharmaceuticals - Indian - Formulations sector. The stock has an ISIN of INE551C01044 and a face value of Rs 1. As of 12 September 2026, it trades at Rs (53.94) with a market capitalisation of Rs 2377.61 crore. Figures are live and subject to change.

Shukra Pharmaceuticals Ltd

Pharmaceuticals - Indian - Formulations
NSE BSE
53.94 -0.03 (-0.06%) downArrowC
As on: 12-Sep-2026 , 02:17 PM
Market Cap(₹Cr) 2377.61
Book Value(₹Cr) 2.2724965
BSE Code : 524632 NSE Symbol : SHUKRAPHAR EPS(TTM) : 0.82 ISIN Demat : INE551C01044 P/E(TTM) : 65.78 Face Value(₹) : 1 Div & Yield % : 0.02

Today Market

Stock Performance

Today Market

Today's High

74,917.15

Todday's Low

74,160.16

Open at

74,309.16

Previous Close

74,902.59

Volumes

Avg Price

-120.83

Historical Performance

News

11 Jun 26
Shukra Pharmaceuticals to conduct EGM
Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 July 2026.
06 Jun 26
Shukra Pharmaceuticals to convene board meeting
Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 June 2026.
08 May 26
Shukra Pharmaceuticals reports consolidated net loss of Rs 1.72 crore in the March 2026 quarter
Net loss of Shukra Pharmaceuticals reported to Rs 1.72 crore in the quarter ended March 2026 as against net profit of Rs 5.
08 May 26
Board of Shukra Pharmaceuticals recommends final dividend
Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 7 May 2026, inter alia, have recommended the final dividend of Rs 0.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-09-26 54.05 55.60 53.75 53.94 1577298 5434 85781102.18 23398.10
10-09-26 57.69 58.20 53.91 53.97 4087812 10346 222893051.31 23477.80
09-09-26 54.98 57.44 54.17 56.10 2827806 8830 157233576.17 23431.50
08-09-26 53.37 56.00 52.21 54.11 6791172 25505 369610205.11 23635.10
07-09-26 51.93 53.59 51.93 53.07 1887833 7414 99905413.20 23779.15
04-09-26 53.39 55.54 51.66 51.93 4036493 13652 215195744.32 23897.70
03-09-26 47.37 54.90 47.10 51.93 8949935 29534 460773294.48 23873.45
02-09-26 44.52 47.24 44.52 46.79 2933344 7002 135806585.30 23914.45
01-09-26 44.54 46.40 44.34 44.43 1832377 3463 82527532.55 24055.80
31-08-26 46.99 46.99 44.29 44.39 1624555 3278 72982293.81 24080.40
123

Fundamentals

Company Valuation

Market Cap (₹cr)

2377.61

PE Ratio

65.78

PB Ratio

23.74

Dividend Yield

0.02

ROE

15.90

ROCE

21.76

Book Value (₹)

2.2724965

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 210250600 47.83 210250600 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 14620000 3.33 14620000 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 224870600 51.15 224870600 7
Total ShareHolding for Promoter & Group 224870600 51.15 224870600 7
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500000 0.11 500000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15000 0.00 15000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 515000 0.12 515000 2
plus  Non Institution
Bodies Corporate 693841 0.16 693831 41
Clearing Members 0 0.00 0 0
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 168360852 38.30 168360852 130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10936361 2.49 10936361 21
Individuals holding nominal share capital up to Rs. 1 lakh 30120745 6.85 29337075 27930
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 4117041 0.94 4029361 253
Sub Total 214228840 48.73 213357480 28375
Total Public Shareholding 214743840 48.85 213872480 28377
Total of Promoter & Public ShareHolding 439614440 100.00 438743080 28384
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 439614440 100.00 438743080 28384

Financials (₹ in cr)

Consolidated Standalone
No Data Available

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 43.7910.953.911.571.571.57
Reserves Total 19.0546.6921.3814.7814.0313.85
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds62.8457.6425.2916.3515.6015.42
Secured Loans 2.701.752.211.100.660.00
Unsecured Loans 1.481.412.872.289.118.05
Total Debt4.183.165.083.389.778.05
Other Liabilities0.130.110.110.000.000.00
Total Liabilities67.1560.9130.4819.7325.3723.47
APPLICATION OF FUNDS :
Gross Block 43.4240.9739.5735.0733.5331.74
Less : Accumulated Depreciation 24.0321.0219.3317.4915.8314.36
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 19.3919.9520.2417.5817.7017.38
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress1.951.661.661.661.661.66
Producing Properties0.000.000.000.000.000.00
Investments 0.000.000.000.000.190.05
Current Assets, Loans & Advances
Inventories 9.952.313.163.951.681.39
Sundry Debtors 8.7724.5130.197.409.757.95
Cash and Bank Balance12.129.983.970.290.500.13
Loans and Advances 34.5919.4215.764.234.134.99
Total Current Assets65.4356.2353.0715.8716.0614.45
Less : Current Liabilities and Provisions
Current Liabilities 13.4812.8741.1912.136.356.46
Provisions 2.740.790.000.000.690.52
Total Current Liabilities & Provisions16.2213.6641.1912.137.046.98
Net Current Assets49.2142.5711.883.759.027.47
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.000.000.000.000.000.00
Deferred Tax Liability3.413.273.293.263.203.10
Net Deferred Tax-3.41-3.27-3.29-3.26-3.20-3.10
Other Assets0.000.000.000.000.000.00
Total Assets67.1460.9030.4819.7325.3623.46
Contingent Liabilities1.401.401.401.400.000.00

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities 1.74-6.684.9412.41-4.52
Investing Activities -1.89-1.53-4.43-1.20-1.26
Net Cash Flow 0.38-0.213.686.012.14
Operating Activities 0.547.993.17-5.207.92

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
DS
Dakshesh Shah
Chairman / Executive Director / Managing Director
Executive
Functional Directors
PM
Payal Mehta
Executive Director
Exec.
DS
Dhruvin Shah
E D & Wholetime Director
Dir.
SP
Sanskruti Patel
E D & Wholetime Director
Dir.
AJP
Anar Jayesh Patel
Executive Director / Whole Time Director / CFO
Exec.
SDS
SHITAL DAKSHESH SHAH
E D & Wholetime Director
Dir.
Independent Directors
PNS
Pinki Nirmal Sagar
Independent Non Exe. Director
Ind.
SDG
Sonal Deepalbhai Gandhi
Independent Non Exe. Director
Ind.
SS
Sarjeevan Singh
Independent Non Exe. Director
Ind.
JS
Jitendra shah
Independent Non Exe. Director
Ind.
RK
Ritu Kapoor
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
SD
Shivkant Dhakad
Company Secretary / Compliance Officer
Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Shukra Pharmaceuticals Ltd? −

Shukra Pharmaceuticals Ltd trades on NSE under SHUKRAPHAR and on BSE under code 524632. The ISIN is INE551C01044 and the face value is Rs 1.

What is the share price of Shukra Pharmaceuticals Ltd today? +

As of 12 September 2026, Shukra Pharmaceuticals Ltd trades at Rs 53.94, a change of -0.03 (-0.06%) on the day. Prices are live and subject to change.

What is the market capitalisation of Shukra Pharmaceuticals Ltd? +

As of 12 September 2026, Shukra Pharmaceuticals Ltd has a market cap of about Rs 2377.61 crore. This figure is live and moves with the share price.

Is Shukra Pharmaceuticals Ltd profitable? +

In , Shukra Pharmaceuticals Ltd reported a profit after tax of Rs crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Shukra Pharmaceuticals Ltd? +

: As of 12 September 2026, the PE (TTM) for Shukra Pharmaceuticals Ltd is 65.78 and the price-to-book ratio is 23.74. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Shukra Pharmaceuticals Ltd pay a dividend? +

As of 12 September 2026, the dividend yield for Shukra Pharmaceuticals Ltd is 0.02%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Shukra Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 51.15% of Shukra Pharmaceuticals Ltd. Public shareholding is 48.85%, including mutual funds at 0.00% and foreign institutional investors at 0.00%.

What were the latest annual financials of Shukra Pharmaceuticals Ltd? +

In , Shukra Pharmaceuticals Ltd reported net sales of Rs crore, revenue growth of %, and earnings per share of Rs .